Fasting plasma levels of glucose, acetoacetate, D-beta-hydroxybutyrate, glycerol, and lactate in the baboon infant: correlation with cerebral uptake of substrates and oxygen.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 403503)

Published in Pediatr Res on April 01, 1977

Authors

L L Levitsky, D E Fisher, J B Paton, C W Delannoy

Articles by these authors

p53 status and the efficacy of cancer therapy in vivo. Science (1994) 6.72

MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature (1998) 3.53

microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev (1994) 3.44

c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev (2000) 3.13

Small nuclear ribonucleoprotein particle assembly in vivo: demonstration of a 6S RNA-free core precursor and posttranslational modification. Cell (1985) 2.36

Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol (1998) 2.20

Idiotype-like molecules on cells of a human T cell leukemia. J Exp Med (1983) 2.19

Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol Cell Biol (1998) 2.11

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child (2004) 2.01

The effects of anorexia nervosa on bone metabolism in female adolescents. J Clin Endocrinol Metab (1999) 1.89

Percutaneous central venous catheterization. Three years' experience in a neonatal intensive care unit. Am J Dis Child (1990) 1.85

atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet (1997) 1.85

Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc Natl Acad Sci U S A (2001) 1.81

Microphthalmia transcription factor. A sensitive and specific melanocyte marker for MelanomaDiagnosis. Am J Pathol (1999) 1.80

Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. J Infect Dis (1983) 1.78

Pre-bending of a promoter sequence enhances affinity for the TATA-binding factor. Nature (1995) 1.74

Synthesis and assembly of human small nuclear ribonucleoproteins generated by cell-free translation. Proc Natl Acad Sci U S A (1983) 1.68

Corticosteroid-induced avascular necrosis. A clinical study of seventy-seven patients. J Bone Joint Surg Am (1971) 1.64

Resurgence of nutritional rickets associated with breast-feeding and special dietary practices. Pediatrics (1980) 1.56

Energy expenditure and body composition in Prader-Willi syndrome. Metabolism (1988) 1.54

A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res (2001) 1.53

Lineage-specific signaling in melanocytes. C-kit stimulation recruits p300/CBP to microphthalmia. J Biol Chem (1998) 1.47

Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell (2001) 1.45

Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum Mol Genet (2000) 1.44

Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol (1997) 1.38

Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab (1994) 1.35

Age-resolving osteopetrosis: a rat model implicating microphthalmia and the related transcription factor TFE3. J Exp Med (1998) 1.35

Histologic demonstration of fat emboli in aseptic necrosis associated with hypercortisonism. Mayo Clin Proc (1969) 1.34

alpha-Melanocyte-stimulating hormone signaling regulates expression of microphthalmia, a gene deficient in Waardenburg syndrome. J Biol Chem (1998) 1.34

Isolation of mouse stromal cells associated with a human tumor using differential diphtheria toxin sensitivity. Am J Pathol (1999) 1.33

Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. J Invest Dermatol (2002) 1.25

Apoptosis and cancer drug targeting. J Clin Invest (1999) 1.22

Diurnal rhythmicity in intestinal SGLT-1 function, V(max), and mRNA expression topography. Am J Physiol Gastrointest Liver Physiol (2001) 1.22

Circadian periodicity of intestinal Na+/glucose cotransporter 1 mRNA levels is transcriptionally regulated. J Biol Chem (1998) 1.18

Effect of androgen on growth hormone secretion and growth in boys with short stature. Acta Endocrinol (Copenh) (1979) 1.13

Psoriasis and Raynaud's phenomenon associated with autoantibodies to U1 and U2 small nuclear ribonucleoproteins. N Engl J Med (1986) 1.10

Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol (2001) 1.10

The role of fat embolism in the etiology of corticosteroid-induced avascular necrosis: clinical and experimental results. Clin Orthop Relat Res (1978) 1.09

The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms. Am J Pathol (2001) 1.08

Genetic interactions between atm and p53 influence cellular proliferation and irradiation-induced cell cycle checkpoints. Cancer Res (1997) 1.07

Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J Biol Chem (2000) 1.07

Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab (1989) 1.05

Pulse labeling of small nuclear ribonucleoproteins in vivo reveals distinct patterns of antigen recognition by human autoimmune antibodies. Proc Natl Acad Sci U S A (1984) 1.04

The semidominant Mi(b) mutation identifies a role for the HLH domain in DNA binding in addition to its role in protein dimerization. EMBO J (1996) 1.04

Sensorineural deafness and pigmentation genes: melanocytes and the Mitf transcriptional network. Neuron (2001) 1.00

Temporal shifts from Sm to ribonucleoprotein reactivity in systemic lupus erythematosus. Arthritis Rheum (1985) 0.99

Autoimmune sera reactive with Sm antigen contain high levels of RNP-like antibodies. J Clin Invest (1985) 0.99

Hemangioendothelioma of the leg following metallic fixation of the tibia. Cancer (1972) 0.98

p53 in life and death. Clin Cancer Res (1996) 0.98

T cell antiidiotypic antibodies reveal differences between two human leukemias. J Exp Med (1984) 0.97

Involvement of microphthalmia in the inhibition of melanocyte lineage differentiation and of melanogenesis by agouti signal protein. J Biol Chem (1998) 0.95

Preserving adult height potential in girls with idiopathic true precocious puberty. J Pediatr (1990) 0.95

Oncogene-dependent regulation of caspase activation by p53 protein in a cell-free system. J Biol Chem (1998) 0.93

Mechanisms of apoptotic cell death. Leukemia (1997) 0.93

Mechanisms of p53-mediated apoptosis. Crit Rev Oncog (1998) 0.92

The leucine zipper may induce electrophoretic mobility anomalies without DNA bending. Proc Natl Acad Sci U S A (1996) 0.91

Extensive apoptosis in ductal carcinoma in situ of the breast. Cancer (1996) 0.91

Apoptosis in tumorigenesis and cancer therapy. Front Biosci (1997) 0.91

Improved oxygenation with prone positioning in neonates: stability of increased transcutaneous PO2. J Perinatol (1991) 0.90

p53 and cancer therapy: a double-edged sword. J Clin Invest (1999) 0.90

Corticosteroid-induced aseptic necrosis. II. Experimental study. Clin Orthop Relat Res (1972) 0.89

Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol (2001) 0.88

"Lineage addiction" in human cancer: lessons from integrated genomics. Cold Spring Harb Symp Quant Biol (2005) 0.88

Cutis laxa, skeletal anomalies, and ambiguous genitalia. Am J Dis Child (1974) 0.87

Echocardiographic evidence for impaired myocardial performance in children with type I diabetes mellitus. Am J Med (1982) 0.87

DNA bending and the curious case of Fos/Jun. Chem Biol (1998) 0.87

Clear cell sarcoma shows immunoreactivity for microphthalmia transcription factor: further evidence for melanocytic differentiation. Mod Pathol (2001) 0.87

Microphthalmia transcription factor: a sensitive and specific marker for malignant melanoma in cytologic specimens. Cancer (2001) 0.86

Uptake and release of energy substrates, oxygen, and carbon dioxide by the hindlimb of the fasting infant baboon. Biol Neonate (1981) 0.84

Dapsone or electric shock therapy of brown recluse spider envenomation? Ann Emerg Med (1994) 0.84

Effect of a large deletion of the basic domain of mi transcription factor on differentiation of mast cells. Blood (2001) 0.84

Murine chromosomal location of five bHLH-Zip transcription factor genes. Genomics (1995) 0.82

Gram-negative bacilli in human milk feedings: quantitation and clinical consequences for premature infants. J Pediatr (1986) 0.82

Assessment of potentially avoidable perinatal mortality in a regionalized program. J Reprod Med (1990) 0.82

Prepubertal gynecomastia associated with estrogen-containing hair cream. Am J Dis Child (1982) 0.82

Precursors to glycogen in ovine fetuses. Am J Physiol (1988) 0.82

A model for the prospective analysis of perinatal deaths in a perinatal network. Am J Obstet Gynecol (1990) 0.81

Glucose regulation of glucose transporters in cultured adult and fetal hepatocytes. Metabolism (1995) 0.81

Key targets for the execution of radiation-induced tumor cell apoptosis: the role of p53 and caspases. Int J Radiat Oncol Biol Phys (2001) 0.81

Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harb Symp Quant Biol (1994) 0.79

Corticosteroid-induced aseptic necrosis. Surg Forum (1969) 0.79

Regulation of melanocyte differentiation and growth. Cell Growth Differ (1997) 0.79

p53, caspase 8, and regulation of apoptosis after ionizing radiation. J Pediatr Hematol Oncol (2001) 0.79

Maturation of gonadotropin and sex steroid responses to gonadotropin-releasing hormone agonist in males. J Clin Endocrinol Metab (1993) 0.79

p53: from molecular mechanisms to prognosis in cancer. J Clin Oncol (1995) 0.78

Distinct mathematical behavior of apoptotic versus non-apoptotic tumor cell death. Int J Radiat Oncol Biol Phys (1999) 0.78

Metabolic response to fasting in experimental intrauterine growth retardation induced by surgical and nonsurgical maternal stress. Biol Neonate (1977) 0.78

The effect of initial Apgar score on the birthweight-specific survival of the very low-birthweight infant. Am J Perinatol (1987) 0.78

Abnormal cardiac function after exercise in insulin-dependent diabetic children and adolescents. Diabetes Care (1987) 0.78

A new test of combined pituitary-testicular function using the gonadotropin-releasing hormone agonist nafarelin in the differentiation of gonadotropin deficiency from delayed puberty: pilot studies. J Clin Endocrinol Metab (1989) 0.78

Celiac plexus blockade for a 3-year-old boy with hepatoblastoma and refractory pain. Pediatrics (1990) 0.77

Anatomy of the pulpal canal: three-dimensional visualization. J Endod (1975) 0.77